Raleigh Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7
| Closed | -$1.05K | – | 651 |
|
|
2025
Q1 | $1.05K | Sell |
7
-7
| -50% | -$1.05K | ﹤0.01% | 454 |
|
|
2024
Q4 | $2.58K | Sell |
14
-3
| -18% | -$554 | ﹤0.01% | 806 |
|
|
2024
Q3 | $3.35K | Buy |
17
+14
| +467% | +$2.76K | ﹤0.01% | 758 |
|
|
2024
Q2 | $620 | Buy |
3
+1
| +50% | +$207 | ﹤0.01% | 893 |
|
|
2024
Q1 | $542 | Buy |
+2
| New | +$542 | ﹤0.01% | 881 |
|
|
2023
Q4 | – | Sell |
-47
| Closed | -$9.21K | – | 1096 |
|
|
2023
Q3 | $9.21K | Buy |
+47
| New | +$9.21K | ﹤0.01% | 552 |
|